Pinatuzumab vedotin

Pinatuzumab vedotin
Monoclonal antibody
Type ?
Source Humanized (from mouse)
Target CD22
Clinical data
ATC code none
Identifiers
CAS Number 1313706-14-7
ChemSpider none
Chemical and physical data
Formula C6748H10377N1773O2083S44
Molar mass 151.1 kg/mol

Pinatuzumab vedotin[1] is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]

This drug was developed by Genentech/Roche.

References

  1. World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 108" (PDF). WHO Drug Information. 26 (4).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Pinatuzumab Vedotin, American Medical Association.
This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.